Politics Medicare obesity drug GLP-1 coverage starting July 1 Finance News Jun 30, 2026 Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of… Read More...
Business Eli Lilly, Regeneron in FDA PreCheck manufacturing program Finance News Jun 29, 2026 Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a… Read More...
Business Medicare will soon cover obesity drugs, but many seniors may not know Finance News Jun 28, 2026 Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news… Read More...
Politics What Pakistan gains from being a peacemaker Finance News Jun 24, 2026 Pakistan's Prime Minister Shehbaz Sharif (R) greets US Vice President JD Vance prior to a quadrilateral meeting… Read More...
Retail Here’s our monthly update on all 35 portfolio stocks, including Cramer’s Finance News Jun 21, 2026 The CNBC Investing Club on Wednesday convened for its June Monthly Meeting, during which Jim Cramer and Jeff Marks,… Read More...
Politics What’s next for the weight loss drug maker Finance News Jun 19, 2026 Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide… Read More...
Business Lilly, Novo, Pfizer look to new weight loss drugs Finance News Jun 13, 2026 Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for… Read More...
Politics Why drug development is heading to orbit Finance News Jun 9, 2026 The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch… Read More...
Politics Weight loss drug maker stock sinks 25% as safety data spooks investors Finance News Jun 8, 2026 Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data on its experimental… Read More...
Politics Biotech M&A hits $106 billion, on track for best year since pre-Covid Finance News Jun 4, 2026 Global biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the… Read More...